Belantamab Mafodotin Combination Therapy
A Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination With Iberdomide (CC-220)/Dexamethasone Versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma
Near Add Your Location
Sorting 35 by
- Not currently accepting
- Show Principal Investigator
Mary Greeley Medical Center
Ames, IA
- Not currently accepting
McFarland Clinic PC
Ames, IA
- Not currently accepting
McFarland Clinic PC (Boone)
Boone, IA
- Not currently accepting
McFarland Clinic Trinity Cancer Center
Fort Dodge, IA
- Not currently accepting
McFarland Clinic PC (Jefferson)
Jefferson, IA
- Not currently accepting
McFarland Clinic PC (Marshalltown)
Marshalltown, IA
- Not currently accepting
- Not currently accepting
Tufts Medical Center Cancer Center
Boston, MA
- Not currently accepting
Columbus Oncology and Hematology Associates
Columbus, OH
- Not currently accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.